Isabelle Chemin, Flor H. Pujol, Caroline Scholtès, Carmen L. Loureiro, Fouzia Amirache, Massimo Levrero, Fabien Zoulim, Jimena Pérez‐Vargas, François‐Loïc Cosset – 6 July 2020
Marco Spada, Roberta Angelico, Chiara Grimaldi, Paola Francalanci, Maria Cristina Saffioti, Andrea Rigamonti, Rosanna Pariante, Roberto Bianchi, Carlo Dionisi Vici, Manila Candusso, Giuseppe Maggiore – 6 July 2020
Surain B. Roberts, Marwa Ismail, Gowthami Kanagalingam, Andrew L. Mason, Mark G. Swain, Catherine Vincent, Eric M. Yoshida, Cynthia Tsien, Jennifer A. Flemming, Harry L.A. Janssen, Gideon M. Hirschfield, Bettina E. Hansen, Aliya F. Gulamhusein, the Canadian Network for Autoimmune Liver Disease – 6 July 2020 – Patients with primary biliary cholangitis (PBC) with incomplete response to ursodeoxycholic acid are at risk of disease progression and need additional therapy.
Nwe Ni Than, Jose Guillain Cataluna, Avik Majumdar – 6 July 2020
Adam E. Mikolajczyk, Nneka Ufere, Anthony C. Breu, Neehar D. Parikh, Guadalupe Garcia‐Tsao, Elliot B. Tapper – 5 July 2020 – #LiverTwitter has emerged as an academic forum that has begun to advance the field of hepatology by disseminating content on chronic liver diseases to a global audience. This article summarizes the content presented in a panel discussion at the 2019 Liver Meeting by highlighting the perspectives of several key types of participants in Twitter: the trainee, the medical educator, the divisional account, the scientific journal, and the passive participant.
Raffaele Brustia, Emmanuel Boleslawski, Antoine Monsel, Louise Barbier, Sébastien Dharancy, René Adam, Jérôme Dumortier, Mickaël Lesurtel, Filomena Conti, Olivier Scatton, Groupe de Recherche Français en Greffe de Foie (GReF²) and the Association de Chirurgie Hépato‐Pancréato‐Biliaire et Transplantation (ACHBT) Collaborative Group – 4 July 2020 – Standardized discharge criteria are critical to reduce premature discharge and avoid unnecessary hospital stays. No such criteria exist for patients undergoing liver transplantation (LT).
Mette Munk Lauridsen, Peter Jepsen, Charlotte Wilhelmina Wernberg, Ove B. Schaffalitzky de Muckadell, Jasmohan S. Bajaj, Hendrik Vilstrup – 3 July 2020 – Minimal hepatic encephalopathy (MHE) is underdiagnosed because most clinics refrain from psychometric testing. Diagnostic activities need to go up so patients with MHE can get the treatment their condition requires. The sickness impact profile questionnaire for covert hepatic encephalopathy (SIPCHE) score is based on quality‐of‐life outcomes and has been proposed as a simple, patient‐administered diagnostic score for grade 1 and MHE.